<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35283082</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>10</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1879-0518</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>110</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>Contraception</Title>
          <ISOAbbreviation>Contraception</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Preliminary side effect profile, safety, and tolerability of hormonal contraception among women receiving opioid-agonist therapy.</ArticleTitle>
        <Pagination>
          <StartPage>16</StartPage>
          <EndPage>20</EndPage>
          <MedlinePgn>16-20</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.contraception.2022.02.013</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0010-7824(22)00061-0</ELocationID>
        <Abstract>
          <AbstractText Label="OBJECTIVE(S)" NlmCategory="OBJECTIVE">To characterize for the first time the side effect profile, safety, and tolerability of hormonal contraception among women receiving opioid-agonist therapy.</AbstractText>
          <AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">We conducted a secondary analysis of data collected from participants in a three-arm randomized controlled trial (N = 138) aimed at increasing effective contraceptive use among women receiving opioid-agonist therapy. Participants in the 2 intervention conditions (n = 90) had free access to hormonal contraception at each of the 14 visits scheduled during the 6-month intervention. Contraceptive use and side effects were recorded at each visit; participants could change methods or discontinue use at any time. Verbatim side effects were classified using Medical Dictionary for Regulatory Activities (MedDRA) terminology.</AbstractText>
          <AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 67 participants reporting hormonal contraceptive use, 29 (43%) initiated implants, 14 (21%) intrauterine devices, 13 (19%) combined pills, 11 (16%) progestin-only pills, 10 (15%) injectables, 1 (2%) ring, and 1 (2%) patch; the average (±standard deviation) duration of use was 129 ± 55, 129 ± 60, 108 ± 62, 102 ± 61, 111 ± 31, 145, and 18 days, respectively. A total of 321 side effects were reported by 55 (82%) participants. Fifty (75%) participants reported menstrual cycle changes/uterine bleeding, followed by headaches (16, 24%), weight gain (15, 22%), and abdominal pain or nausea/vomiting (11, 16%). No serious side effects were reported. Twelve participants (18%) changed methods and 13 (19%) discontinued all hormonal contraceptive use.</AbstractText>
          <AbstractText Label="CONCLUSION(S)" NlmCategory="CONCLUSIONS">The hormonal contraceptive side effects reported by this small group of women receiving opioid-agonist therapy appear consistent with those reported by the general population, was generally well-tolerated, and did not raise safety concerns.</AbstractText>
          <AbstractText Label="IMPLICATIONS" NlmCategory="CONCLUSIONS">These results provide important preliminary evidence that hormonal contraceptive use produces a familiar side effect profile and is well-tolerated by women receiving opioid-agonist therapy, although studies with larger samples followed over longer periods of time with appropriate comparison conditions are needed to fully assess tolerability and safety.</AbstractText>
          <CopyrightInformation>Copyright © 2022. Published by Elsevier Inc.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Melbostad</LastName>
            <ForeName>Heidi S</ForeName>
            <Initials>HS</Initials>
            <AffiliationInfo>
              <Affiliation>Vermont Center on Behavior and Health, Burlington, VT, United States; Department of Psychiatry, Larner College of Medicine, University of Vermont, Burlington, VT, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wachtel</LastName>
            <ForeName>Deborah S</ForeName>
            <Initials>DS</Initials>
            <AffiliationInfo>
              <Affiliation>Vermont Center on Behavior and Health, Burlington, VT, United States; College of Nursing and Health Sciences, University of Vermont, Burlington, VT, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Lipke</LastName>
            <ForeName>Kerstin A</ForeName>
            <Initials>KA</Initials>
            <AffiliationInfo>
              <Affiliation>Vermont Center on Behavior and Health, Burlington, VT, United States; Department of Psychiatry, Larner College of Medicine, University of Vermont, Burlington, VT, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Badger</LastName>
            <ForeName>Gary J</ForeName>
            <Initials>GJ</Initials>
            <AffiliationInfo>
              <Affiliation>Vermont Center on Behavior and Health, Burlington, VT, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Matusiewicz</LastName>
            <ForeName>Alexis K</ForeName>
            <Initials>AK</Initials>
            <AffiliationInfo>
              <Affiliation>Vermont Center on Behavior and Health, Burlington, VT, United States; Department of Psychiatry, Larner College of Medicine, University of Vermont, Burlington, VT, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Rey</LastName>
            <ForeName>Catalina N</ForeName>
            <Initials>CN</Initials>
            <AffiliationInfo>
              <Affiliation>Vermont Center on Behavior and Health, Burlington, VT, United States; Department of Psychiatry, Larner College of Medicine, University of Vermont, Burlington, VT, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>MacAfee</LastName>
            <ForeName>Lauren K</ForeName>
            <Initials>LK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics, Gynecology, and Reproductive Sciences, Larner College of Medicine, University of Vermont, Burlington, VT, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Dougherty</LastName>
            <ForeName>Anne K</ForeName>
            <Initials>AK</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Obstetrics, Gynecology, and Reproductive Sciences, Larner College of Medicine, University of Vermont, Burlington, VT, United States.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Heil</LastName>
            <ForeName>Sarah H</ForeName>
            <Initials>SH</Initials>
            <AffiliationInfo>
              <Affiliation>Vermont Center on Behavior and Health, Burlington, VT, United States; Department of Psychiatry, Larner College of Medicine, University of Vermont, Burlington, VT, United States; Department of Psychological Science, University of Vermont, Burlington, VT, United States. Electronic address: sarah.heil@uvm.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>03</Month>
          <Day>11</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <Country>United States</Country>
        <MedlineTA>Contraception</MedlineTA>
        <NlmUniqueID>0234361</NlmUniqueID>
        <ISSNLinking>0010-7824</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000701">Analgesics, Opioid</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D003270">Contraceptive Agents</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000701" MajorTopicYN="Y">Analgesics, Opioid</DescriptorName>
          <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003267" MajorTopicYN="N">Contraception</DescriptorName>
          <QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003270" MajorTopicYN="N">Contraceptive Agents</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000080282" MajorTopicYN="N">Hormonal Contraception</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007434" MajorTopicYN="Y">Intrauterine Devices</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014592" MajorTopicYN="N">Uterine Hemorrhage</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">Hormonal contraception</Keyword>
        <Keyword MajorTopicYN="N">Hormonal contraceptive use</Keyword>
        <Keyword MajorTopicYN="N">Opioid use disorder</Keyword>
        <Keyword MajorTopicYN="N">Opioid-agonist therapy</Keyword>
        <Keyword MajorTopicYN="N">Safety</Keyword>
        <Keyword MajorTopicYN="N">Side effects</Keyword>
        <Keyword MajorTopicYN="N">Tolerability</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>28</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>14</Day>
          <Hour>5</Hour>
          <Minute>42</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35283082</ArticleId>
        <ArticleId IdType="doi">10.1016/j.contraception.2022.02.013</ArticleId>
        <ArticleId IdType="pii">S0010-7824(22)00061-0</ArticleId>
      </ArticleIdList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
